CTS2444-32 reduced inflammation in the brain and lowered levels of toxic proteins (IMAGE)
Caption
The compound CTS2444-32 showed strong results in models of slowing the onset of Parkinson's disease and reducing inflammation caused by acute lung injury, a serious condition that can occur during illnesses like sepsis or when patients require ventilators.
Credit
Aileen Sola/Florida International University
Usage Restrictions
None
License
Original content